Minimally Invasive Method for Treating Tonsillar Hypertrophy

Roughly 530,000 tonsillectomies areperformed annually in the United States which can result in post-surgicalcomplications like bleeding, vomiting and dehydration, infection andvelopharyngeal insufficiency. Furthermore, the tonsils are important inmounting an immune response against bacteria and viruses. Dr. Cho has inventeda medical instrument and method for delivering drugs into tonsillar and othertissue as an alternative to tonsillectomy and adenoidectomy procedures. Theinstrument will be tonsil-accessible whereby a needle head with microneedlescan be disposed onto the tonsil or adenoid for site-specific, controlled andsustained drug delivery. The global market for needle-free injectors whichincludes microneedle technology was worth $607 million in 2017. The market isexpected to increase at a compound annual growth rate (CAGR) of 10.4% duringthe forecast period 2018-2023 reaching $1.1 billion. Sathya Balachander sathyab@uab.edu (205) 975-6851

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More